(Q33477440)

27 July 2017

1 reference

reason for preferred rank

title

Amrinone A Preliminary Review of its Pharmacological Properties and Therapeutic Use (English)

1 reference

10.2165/00003495-198326060-00002

https://api.crossref.org/works/10.2165/00003495-198326060-00002

7 October 2023

Amrinone. A preliminary review of its pharmacological properties and therapeutic use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360634

7 October 2023

2

Brogden RN

1 reference

27 July 2017

A. Ward

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360634

7 October 2023

R. C. Heel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360634

7 October 2023

T. M. Speight

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360634

7 October 2023

G. S. Avery

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360634

7 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6360634

7 October 2023

publication date

1 December 1983

1 reference

27 July 2017

1 reference

27 July 2017

volume

26

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

468-502

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198326060-00002

27 July 2017

exact match

0 references

cites work

High-performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog

1 reference

12 December 2020

Thrombocytopenia and fever in a patient taking amrinone

1 reference

12 December 2020

Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle

1 reference

12 December 2020

Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation

1 reference

12 December 2020

Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate

1 reference

12 December 2020

Oral amrinone in refractory congestive heart failure

1 reference

12 December 2020

Amrinone and exercise performance in patients with chronic heart failure

1 reference

12 December 2020

Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog

1 reference

12 December 2020

Acute pharmacodynamics and pharmacokinetics of oral amrinone

1 reference

12 December 2020

Hemodynamic effects of various doses of a new inotropic: amrinoma

1 reference

12 December 2020

Clinical experience with amrinone in patients with advanced congestive heart failure

1 reference

12 December 2020

Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function

1 reference

12 December 2020

Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.

1 reference

12 December 2020

Cardiotonic agents in the management of chronic cardiac failure

1 reference

12 December 2020

Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes

1 reference

12 December 2020

Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance

1 reference

12 December 2020

Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]

1 reference

12 December 2020

1 reference

12 December 2020

Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.

1 reference

12 December 2020

Problems in assessment of new pharmacologic agents for the heart failure patient

1 reference

12 December 2020

Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence.

1 reference

12 December 2020

Effects of amrinone on the tracheal musculature and vasculature of the dog

1 reference

12 December 2020

Pharmacological actions of various inotropic agents

1 reference

12 December 2020

Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease

1 reference

12 December 2020

Metabolism of amrinone in animals

1 reference

12 December 2020

Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure

1 reference

12 December 2020

Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function

1 reference

12 December 2020

Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure

1 reference

12 December 2020

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

12 December 2020

Inotropic and electrophysiologic effects of amrinone in untreated and digitalized ventricular tissues

1 reference

12 December 2020

The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscle

1 reference

12 December 2020

Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration

1 reference

12 December 2020

Side effects of amrinone therapy

1 reference

12 December 2020

Effects of amrinone on experimental acute myocardial ischaemic injury

1 reference

12 December 2020

Effects of amrinone on atrioventricular conduction in the intact canine heart

1 reference

12 December 2020

Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.

1 reference

12 December 2020

Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure

1 reference

12 December 2020

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

12 December 2020

The effects of amrinone on transport and cyclic AMP metabolism in toad urinary bladder

1 reference

12 December 2020

Relationship between amrinone plasma concentration and cardiac index

1 reference

12 December 2020

Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043

1 reference

12 December 2020

Amrinone activates K+-depolarized atrial and ventricular myocardium of guinea pigs

1 reference

12 December 2020

Direct vasodilator and positive inotropic actions of amrinone

1 reference

12 December 2020

Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs

1 reference

12 December 2020

Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.

1 reference

12 December 2020

Differential effects of amrinone on contractility and taurine influx in rat and guinea pig hearts

1 reference

12 December 2020

The role of cyclic adenosine 3', 5'-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle

1 reference

12 December 2020

10.2165/00003495-198326060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

1022625346

0 references

1 reference